Impact Factor
4.28
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.09
3,553 total citations
h5-index
73
h5 depth signal
Cited share
77.5%
468 of 604
Total citations
3,553
Citation footprint
Metric signal
5.48
External metric anchor
Self-citation
2.2%
79 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,943
Canada
301
United Kingdom
237
France
208
China
176
Citing Fields of Research
Oncology
1,310
Breast Cancer
735
Liver & Colon Cancer
282
Palliative Care
219
Lung Cancer
209
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
32,502
Articles tracked across the journal lifetime
Indexed publication set
604
468 cited publications
Last 12 months
442
36.8 publications/month
Open access share
28.1%
124 OA publications in the last year
Leading citing country
United States
1,943 citing publications
Leading citing field
Oncology
1,310 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v34n6, June 1965-
v34n6, June 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Liver & Colon Cancer
Lung Cancer
Prostate Cancer
Issuing & Sponsoring Bodies
Contributor
National Cancer Institute (U.S.)
Contributor
National Institutes of Health (U.S.)
Broad Categories
Neoplasms
Palliative Care
Breast Cancer
Oncology
Genetics & Genomics
Liver & Colon Cancer
Lung Cancer
Medical Ethics
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/jnci/djag395
Open DOI
Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling study
Background: Lack of health insurance limits access to health care, leading to potentially preventable inequities in health outcomes. This modelling study estimates the impact of providing insurance to currently uninsured individuals on c...
02
DOI 10.1093/jnci/djag390
Open DOI
Novel framework for the validation of intermediate clinical endpoints in oncology real-world data
Introduction: The role of real-world data in oncology has been substantially increasing, helping to answer clinically unmet needs. No valid framework for real-world data is currently available for the evaluation of surrogate endpoints, w...
03
DOI 10.1093/jnci/djag217
Open DOI
Identification of prediagnostic proteomic biomarkers for colon and rectal cancer in 3 prospective cohorts
Background: Large-scale proteomics may reveal circulating biomarkers of colorectal cancer (CRC) years before diagnosis, yet cross-cohort reproducibility and anatomic site-specificity remain unclear. Methods: We conducted nested case-cont...
04
DOI 10.1093/jnci/djag375
Open DOI
Time trends of human papillomavirus-attributable head and neck cancers: the BROADEN study
Background: The incidence of human papillomavirus (HPV)-driven oropharyngeal cancer (OPC) is increasing in several Western countries, but this trend is less well understood in other geographical regions and for other head and neck cancer...
05
DOI 10.1093/jnci/djag392
Open DOI
Colonoscopy screening outcomes in Lynch syndrome and differential colorectal cancer paths among MLH1 / MSH2 carriers
Backgroud: Lynch syndrome, caused by pathogenic variants in mismatch repair genes increases the risk of colorectal cancer, which remains elevated even under active colonoscopy surveillance. A deeper understanding of the underlying mechan...
06
DOI 10.1093/jnci/djag393
Open DOI
Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium
Background: Many effective anti-cancer modalities potentially induce cardiotoxicity. Pediatric patients with relapsed/refractory hematologic malignancies are often excluded from anthracycline-containing regimens based on historical data ...
07
DOI 10.1093/jnci/djag327
Open DOI
Claims-based frailty, dual eligibility, and potential unmet home-health needs in older breast cancer survivors
Background: Older breast cancer survivors often need home-based functional support, yet whether Medicare’s restricted home health (HH) benefit leaves frailty-related need unmet at the population level is not quantified because measuremen...
08
DOI 10.1093/jnci/djag394
Open DOI
Lifestyle and genetic risk factors for postmenopausal breast cancer in the multiethnic cohort
Background: Adherence to a healthy lifestyle has been consistently associated with reduced breast cancer risk, but whether this benefit varies by genetic susceptibility remains unclear, particularly among racially and ethnically diverse ...
09
DOI 10.1093/jnci/djag330
Open DOI
Improved adverse event reporting: it’s about time
10
DOI 10.1093/jnci/djag364
Open DOI
Trends in incidence rates of uterine corpus cancer by birth cohort in 24 countries, 1998-2017
Background: Increases in uterine corpus cancer incidence have been reported in multiple countries, with age-specific patterns suggesting a possible birth cohort effect. However, most studies rely on period-based approaches, limiting char...
Bibliographical & Catalog Notes
As of <2002->, online version has title: JCNI cancer spectrum.
Abstracts of papers contained in the journal accompany each issue.
No longer an official government publication; no longer distributed to depository libraries after Dec. 2002.
Place of publication varies.
Supplements accompany some numbers.
Also issued online.
Indexes: Vols. 1-16, 1940-56. 1 v.
Vol. 87, no. 5 (MAR 1995)19950517 Notice not published Printed on acid-free paper